Lloyd Price

NOVEMBER 21, 2023

Engage with Stakeholders: Actively engage with NHS staff, patients, and advocacy groups to understand their concerns and address them proactively. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Open communication and collaboration will foster trust and support.

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Healthcare IT Today

MAY 22, 2023

“We are excited to have the support of such a strong group of investors who share our mission of unlocking the power of data to improve health,” said Sundeep Bhan, CEO at Prognos Health.

Life Science 59

Life Science Drug Development Health IT Healthcare IT 59

Digital Health Global

JANUARY 4, 2024

This new publication builds upon research conducted by Dr. Nitin Ohri at Montefiore Medical Center in collaboration with Koneksa, presented at 2023 ASCO Quality Care. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.

Digital Health 88

Digital Health Health Technology Drug Development healthcare technology 88

Digital Health Global

SEPTEMBER 27, 2023

With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program.

Life Science 88

Life Science Drug Development HC BioTech 88

Healthcare IT Today

NOVEMBER 14, 2022

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Society for Participatory Medicine

AUGUST 17, 2022

For a person like me, who is impacted by a rare, neurological, and incurable disease, it’s my mission to ensure that patients’ perspectives are represented early and throughout drug development. We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps.

Drug Development 93

Drug Development BioTech 93

Healthcare IT Today

OCTOBER 6, 2023

The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S.,

Life Science 99

Life Science Drug Development Pharmaceuticals Health IT 99

Digital Health Global

FEBRUARY 16, 2023

“Avilar is pioneering the next frontier in protein degradation and we are excited that our significant progress over the past year in discovering and advancing extracellular protein degraders has attracted this group of leading investors,” said Daniel Grau, CEO and President of Avilar Therapeutics.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Collaboration between these groups will be crucial to unlocking the full potential of GenAI and shaping a healthier future for all. But how can healthcare organisations best leverage this technology?

healthcare technology 73

healthcare technology Leadership Drug Development Digital Health 73

Lloyd Price

JUNE 4, 2018

and The Up Group recently hosted a breakfast on ‘Female Health Innovation’, often known as FemTech. CVC’s recent acquisition of the women’s health division of the Israeli drug developer Teva for $800m created a company dedicated to contraception, fertility, menopause and osteoporosis. Silicon Valley Bank, Zinc.vc

Mental health 49

Mental health Drug Development Health Data 49

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Insulin Nation

NOVEMBER 27, 2018

In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. His group also published a paper on ‘triple therapy’ which included liraglutide and dapagliflozin in addition to insulin in patients with type 1 diabetes.

Drug Development 70

Drug Development 70

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A The company is headquartered in Lexington, Massachusetts. Click here for more information.

Pharmaceuticals 59

Pharmaceuticals Drug Development Medical Technology Healthcare IT 59

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” Evinova is a health-tech business within the AstraZeneca Group.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

mHealth Insight

APRIL 24, 2018

The global pharmaceutical industry has seen a downturn in recent years because of the challenges and cost associated with pharmaceutical development, procrastination in drug development, etc. Victor Sastre, Senior MSL, Coordinator of the MSL Working Group AMIFE. Clinical trials field is also faced with such challenges.

Pharmaceuticals 28

Pharmaceuticals Drug Development 28

Digital Health Today

AUGUST 7, 2019

DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drug development and speeding up that phase. Healthcare professionals are a very important group to adopt DTx but education is essential for them to understand the benefits and how to use DTx.

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Big Pharma is driving much of the speculation. Several big players have joined the DTA, which doubled in membership in 2022. They include Astellas Pharma Inc.,

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Lloyd Price

MAY 18, 2021

Yaron Gissin, Chief Innovation Officer of the Sade Group, explores the benefits of individually personalised medicine via digital data and tools. A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3. PNAS Nov 2020; vol. 117(45) 2 Leader, The Economist.

Drug Development 64

Drug Development Pharmaceuticals Psychiatry Telemedicine 64

Healthcare IT Today

MAY 5, 2023

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.

Drug Development 87

Drug Development Primary Care Remote care Patient Experience 87

Henry Kotula

MARCH 10, 2021

At life sciences companies, AI is primarily deployed during the drug development process to improve record-keeping and the application process, the survey found. The Consumer Technology Association (CTA) created a working group two years ago to develop some standardization on definitions and characteristics of healthcare AI.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.

Drug Development 64

Drug Development BioTech Pharmaceuticals Health IT 64

Healthcare IT Today

APRIL 25, 2024

The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease. The US has the highest rate of avoidable cancer and cardiometabolic-related deaths among any high-income country. “At

Drug Development 100

Drug Development healthcare technology Health IT Healthcare IT 100

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward.

Connected Health 183

Connected Health Telehealth Pharmaceuticals EHR 183

Healthcare IT Today

JANUARY 9, 2023

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Can they see changes locally in the tumor microenvironment that indicate the drug is having a biology effect? Kimberly Powell, Vice President of Healthcare at NVIDIA.

Health IT 88

Health IT Pharmaceuticals Drug Development Life Science 88

Healthcare IT Today

JANUARY 17, 2024

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. While there are many discussions and pilots happening currently, 2024 will be the year we see both of these groups push their institutions for real-life implementations.

Health IT 106

Health IT Mental health Interoperability Patient Experience 106